Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photodynamic Therapy vs Chemopeeling for Multiple Actinic Keratoses on the Underarms
2004-004258-26Phase 3Completed
- Sponsor
- Division of Special and Environmental Dermatology
- Start
- May 2005
- Modality
- Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of 5-aminolevulinic acid and trichloroacetic acid in actinic keratosis (AK) (2 arms), sponsored by Division of Special and Environmental Dermatology. Primary endpoint: Lesion clearance at 52 weeks. Started May 2005; status: completed.
02
Drugs
5-aminolevulinic acidtrichloroacetic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on 2004-004258-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004258-26.